Sihuan Pharma’s Botox Beauty Bid Suffers Covid Wrinkle
The cardiovascular and cancer drug maker’s recent shift to the medical beauty business was doing well at first, but struggled last yearKey Takeaways:Sihuan Pharmaceutical’s recent move into the medical beauty…
Recent Articles
RELATED ARTICLES
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG
- Eternal Beauty struts its stuff as Hong Kong’s newest IPO contestant
- Innogen Pharma jostles for a slice of the weight-loss market
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
Discover hidden China stock gems in our weekly newsletter